⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ANTX News
AN2 Therapeutics, Inc. Common Stock
Beyond Housing: Building a Broader Strategy for Health and Well-Being
accessnewswire.com
CVS
ANTX
AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(c)(4)
businesswire.com
ANTX
Bioconjugation Market Report 2026: Global Size, Share, Trends and 2030 Forecast | Capitalize on Targeted Therapeutics | Thermo Fisher, Merck, Danaher, Lonza, and Agilent Lead the Industry
globenewswire.com
TMO
MRK
DHR
ANTX
Tumor Ablation Market Set to Surge to US$ 1.8 Billion by 2031, Growing at 11.6% CAGR: Wissen Research
prnewswire.com
BSX
JNJ
ANTX
STRC
CNMD
MMSI
Global Breast Biopsy Devices Market Size, Share, Trends, and Forecast, 2026-2036 | AI-Guided Biopsy and Screening Expansion Drive 7.6% CAGR Toward USD 4.52 Billion
globenewswire.com
HOLX
DHR
BDX
MMSI
ARGX
GEHC
ANTX
Buerger's Disease (Thromboangiitis Obliterans) 7MM Market Insights, Epidemiology, and Forecast - 2036 | No Approved Therapies and Sparse Pipeline Signal First-Mover Opportunity
globenewswire.com
ANTX
AN2 Therapeutics, Inc. Reports Inducement Grants under Listing Rule 5635(c)(4)
businesswire.com
ANTX
AN2 Therapeutics Presents Clinical and Translational Data Supporting Development of Epetraborole for Polycythemia Vera at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting
businesswire.com
ANTX
AN2 Therapeutics Appoints Cameron Trenor, M.D., as Chief Medical Officer
businesswire.com
ANTX
Form 8-K
sec.gov
ANTX